Skip to page content

TriVirum appears to raise $9.1 million for medical device development


medical technology network
Medical technology startup TriVirum appears to have raised $9.1 million in equity funding.
utah778

Sacramento startup medical technology company TriVirum Inc. has raised $9.1 million in equity funding, a filing with the Securities and Exchange Commission appears to show.

TriVirum is developing inexpensive and wearable signal-processing medical sensor devices.

Last spring, when Trivirum raised $3 million, the company’s executive officer and consultant Bill Willis said TriVirum was still in stealth mode.

The company has not returned emails and calls since it raised the new money, which was reported to the SEC on Jan. 2.

Last spring, TriVirum raised $3 million of the $4 million in equity funding it was seeking, according to a filing with the SEC.

In the most recent round, the company raised $9.1 million of the nearly $9.4 million it was seeking, the filing shows.

Broadly, TriVirum uses advanced semiconductor and signal processing technology to build inexpensive medical devices.

The company's product was studied in clinical trials at the Clayton Sleep Institute in St. Louis in the summer of 2023, according to the National Institutes of Health’s National Library of Medicine website ClinicalTrials.gov.

The TriVirum product was under study for use in monitoring symptomatic or asymptomatic adults at risk of developing or who have atrial fibrillation. Atrial fibrillation is an irregular or rapid heart rhythm. The wearable device was tested in adults aged 65 to 90. No results are posted on the device’s test, which ran over a seven-day period.

TriVirum's goal is to create cost-effective, medical-quality sensors that provide doctors with actionable information about a patient’s health. With the first product, that is information about the patient's heart health.

Willis, who is listed as a director of the company in addition to being an officer of TriVirum, is also managing director of Key Harbor Group LLC, a medical technology consulting firm in Seattle.

TriVirum’s chief financial officer is Yasmin Seyal. She was previously CFO of GenCorp Inc., before the Rancho Cordova-based aerospace company changed its name to Aerojet Rocketdyne. Seyal is also the former global treasurer of Rancho Cordova-based eye-care company VSP Vision. In recent years, she’s been working with startup companies.


Keep Digging

Fundings
Awards
Awards


SpotlightMore

Image via Getty
See More
SPOTLIGHT Awards
See More
Image via Getty Images
See More
SPOTLIGHT Tech News from the Local Business Journal
See More

Upcoming Events More

Want to stay ahead of who & what is next? The national Inno newsletter is your definitive first-look at the people, companies & ideas shaping and driving the U.S. innovation economy.

Sign Up
)
Presented By